Ajo LP Invests $652,000 in LivaNova PLC (LIVN) Stock
Ajo LP purchased a new position in shares of LivaNova PLC (NASDAQ:LIVN) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,657 shares of the company’s stock, valued at approximately $652,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Franklin Resources Inc. increased its position in LivaNova PLC by 7.5% during the second quarter. Franklin Resources Inc. now owns 5,089,070 shares of the company’s stock worth $311,515,000 after buying an additional 354,956 shares during the period. FMR LLC increased its position in LivaNova PLC by 74.9% during the first quarter. FMR LLC now owns 4,817,815 shares of the company’s stock worth $236,118,000 after buying an additional 2,063,196 shares during the period. BlackRock Inc. increased its position in LivaNova PLC by 16,157.4% during the first quarter. BlackRock Inc. now owns 2,592,889 shares of the company’s stock worth $127,077,000 after buying an additional 2,576,940 shares during the period. State Street Corp increased its position in LivaNova PLC by 0.3% during the first quarter. State Street Corp now owns 1,050,160 shares of the company’s stock worth $51,469,000 after buying an additional 2,913 shares during the period. Finally, Vanguard Group Inc. increased its position in LivaNova PLC by 4.5% during the first quarter. Vanguard Group Inc. now owns 777,356 shares of the company’s stock worth $38,098,000 after buying an additional 33,645 shares during the period. 82.26% of the stock is currently owned by institutional investors.
Several research analysts have commented on LIVN shares. Jefferies Group LLC lifted their price target on LivaNova PLC from $76.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, September 15th. Needham & Company LLC raised LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a report on Friday, September 15th. Berenberg Bank reissued a “buy” rating and issued a $70.00 target price on shares of LivaNova PLC in a report on Friday, August 11th. BidaskClub lowered LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, Canaccord Genuity reissued a “hold” rating and issued a $71.00 target price on shares of LivaNova PLC in a report on Wednesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company’s stock. LivaNova PLC has a consensus rating of “Hold” and an average target price of $71.50.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total value of $60,760.00. Following the sale, the director now owns 58,296 shares of the company’s stock, valued at approximately $3,542,064.96. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In the last three months, insiders sold 3,000 shares of company stock worth $190,860. Company insiders own 0.28% of the company’s stock.
LivaNova PLC (LIVN) opened at 68.63 on Thursday. The stock has a 50 day moving average price of $62.98 and a 200-day moving average price of $57.94. The firm has a market cap of $3.35 billion, a price-to-earnings ratio of 122.55 and a beta of 0.58. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $69.78.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.19. The business had revenue of $321.40 million for the quarter, compared to the consensus estimate of $315.75 million. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The business’s revenue for the quarter was up .1% on a year-over-year basis. Equities analysts forecast that LivaNova PLC will post $3.24 earnings per share for the current year.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.